GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons
The Administrators of the GlaxoSmithKline US Deferred Performance Share Plan (the Plan) notified the Company and the under-mentioned Director and Person Discharging Managerial Responsibilities ('PDMR') on 24 July 2015 of the following increase in his interests in American Depositary Shares ('ADSs') at a price of $41.80 per ADS following the re-investment of the dividend paid to shareholders on 9 July 2015.
Director/PDMR
|
ADSs |
Dr M M Slaoui |
288.361 |
Mr D E Troy |
387.958 |
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
24 July 2015